首页> 美国卫生研究院文献>British Journal of Cancer >Search for germline alterations in CDKN2A/ARF and CDK4 of 42 Jewish melanoma families with or without neural system tumours
【2h】

Search for germline alterations in CDKN2A/ARF and CDK4 of 42 Jewish melanoma families with or without neural system tumours

机译:在42个有或没有神经系统肿瘤的犹太黑素瘤家族中寻找CDKN2A / ARF和CDK4的种系改变

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

To gain insight into the molecular mechanisms involved in the inherited predisposition to melanoma and associated neural system tumours, 42 Jewish, mainly Ashkenazi, melanoma families with or without neural system tumours were genotyped for germline point mutations and genomic deletions at the CDKN2A/ARF and CDK4 loci. CDKN2A/ARF deletion detection was performed using D9S1748, an intragenic microsatellite marker. Allele dosage at the p14ARF locus was analysed by quantitative real-time PCR employing a TaqMan probe that anneals specifically to exon 1β of the p14ARF gene. For detecting point mutations, dHPLC and direct sequencing of the coding sequences of CDKN2A/ARF and CDK4 was used. No germline alterations in any of the tested genes were detected among the families under study. We conclude that in the majority of Ashkenazi Jewish families, the genes tested are unlikely to be implicated in the predisposition to melanoma and associated neural system tumours.
机译:为了深入了解遗传性黑素瘤易感性和相关神经系统肿瘤的分子机制,对42个犹太人(主要是阿什肯纳兹族)的有或没有神经系统肿瘤的黑素瘤家族进行了基因型分型,以检测CDKN2A / ARF和CDK4的种系点突变和基因组缺失位点。使用基因内微卫星标记D9S1748进行CDKN2A / ARF缺失检测。通过定量实时PCR,使用TaqMan探针对p14 ARF 基因的等位基因剂量进行定量分析,该探针与p14 ARF 基因的外显子1β特异性退火。为了检测点突变,使用了dHPLC和CDKN2A / ARF和CDK4编码序列的直接测序。在研究的家庭中,未检测到任何测试基因的种系改变。我们得出结论,在大多数阿什肯纳兹犹太人家庭中,测试的基因不太可能与黑色素瘤和相关神经系统肿瘤的易感性有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号